N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-methyl-L-tyrosine>98.0%(HPLC)(T)5g

TERT-BUTYL 6-FLUORO-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDOLE-1-CARBOXYLATE, 95.0%, 5g

Methyl 5-bromo-6-methylpicolinate, 97%, 100mg

ethyl 6-[3-(morpholinomethyl)phenyl]-6-oxohexanoate, 97.0%, 1g

2-Cyclohexyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

CLINAFLOXACIN, 95%, 250mg

2,2-DIETHOXYACETIC ACID, 95%, 5g

(4-BENZYL-6,6-DIMETHYLMORPHOLIN-2-YL)METHANOL, 95.0%, 1g

4-(3-Fluorophenyl)-piperidine hydrochloride, 97.0%, 10g

GC capillary column ROTI®Cap-FFAP, 50 m, 0.25 mm, 0.25 µm, 1 Piece(s)

(S)-2-Hydroxy-4-phenylbutyric acid, 95.0%, 5g

3-Chlorophenethyl alcohol, 95.0%, 10g

2-(6-methylpyridin-2-yl)-1,3-dioxoisoindoline-5-carboxylic acid, 95.0%, 5g